Oral secretory leukocyte protease inhibitor (SLPI): Associations with oropharyngeal cancer and treatment outcome.

Brittney L DickeyBradley SirakLaura Martin-GomezRichard R ReichMartha AbrahamsenKimberly Isaacs-SorianoChristine H ChungAnna R Giuliano

Published in: PloS one (2021)

Salivary SLPI was not associated with OPC risk but was associated with higher odds of an incomplete treatment response.

Keyphrases